Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ · Healthcare
Madrigal Pharmaceuticals, Inc. Income Statement 2012–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenue | 958.4M | 180.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 147,000 |
| Gross Profit | — | 173.9M | 0 | 0 | — | — | — | — | — | — |
| Profitability | ||||||||||
| Operating Income | -300.1M | -497.9M | -380.5M | -293.6M | -242.5M | -206.7M | -95.0M | -40.7M | -32.1M | -60.9M |
| EBITDA | -298.6M | -496.8M | -380.0M | -293.1M | -242.1M | -206.2M | -94.9M | -40.6M | -32.0M | -60.2M |
| Net Income | -288.3M | -465.9M | -373.6M | -295.4M | -241.8M | -202.2M | -83.9M | -32.8M | -31.2M | — |
| Per Share Data | ||||||||||
| EPS (diluted) | $-12.85 | $-21.90 | $-19.99 | $-17.23 | $-14.63 | $-13.09 | — | — | — | — |
| Shares Outstanding (dil.) | 22M | 21M | 19M | 17M | 17M | 15M | 15M | 15M | 14M | 69M |
Madrigal Pharmaceuticals, Inc. Income Statement — FAQ
Madrigal Pharmaceuticals, Inc. (MDGL) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MDGL's income statement history?
The chart and table above show Madrigal Pharmaceuticals, Inc.'s income statement by year and by quarter, including the growth rate.